NCT04413032View on ClinicalTrials.gov

DreaMS - Digital Biomarkers for Multiple Sclerosis

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

October 5, 2020

Primary Completion Date

February 26, 2021

Study Completion Date

February 26, 2021

Conditions
Multiple Sclerosis
Interventions
DEVICE

DreaMS

The dreaMS App is a data communication platform collecting data from the patients' mobile devices (smartphone and wearables). We analyze app-based tests, surveys and sensor data.

Trial Locations (1)

4031

RC2NB, Basel

All Listed Sponsors
lead

Research Center for Clinical Neuroimmunology and Neuroscience Basel

OTHER

NCT04413032 - DreaMS - Digital Biomarkers for Multiple Sclerosis | Biotech Hunter | Biotech Hunter